Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 6/20 | 0.69 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.69 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.69 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.69 |
| ▸ | HTR2A | P28223 | 2/20 | 0.69 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.69 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.69 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.69 |
| ▸ | ACHE | P22303 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9721972 | 0.86 | CYP2D6 (0.74) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| SCHEMBL9858161 | 0.86 | CYP2D6 (0.74) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| SCHEMBL10932466 | 0.85 | CYP2D6 (1.00) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| SCHEMBL9722034 | 0.84 | CYP2D6 (0.72) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| SCHEMBL9722081 | 0.84 | CYP2D6 (0.72) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| SCHEMBL9722021 | 0.84 | CYP2D6 (0.72) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| SCHEMBL9721988 | 0.83 | CYP2D6 (0.70) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| SCHEMBL10616029 | 0.82 | CYP2D6 (0.68) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| Butenafine SCHEMBL65526 | 0.82 | CYP2D6 (1.00) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 | |
| SCHEMBL9821873 | 0.82 | CYP2D6 (0.68) | CYP2D6CYP1A2CYP2C19LMNASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100144733-A1 | Compounds, compositions and methods comprising heteroaromatic derivatives | INSTITUTE FOR ONEWORLD HEALTH | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144733-A1 | Compounds, compositions and methods comprising heteroaromatic derivatives | CFTR, PKD1, PKD2 | CYP2D6 1205/4885CYP1A2 2249/4885CYP2C19 1247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.